BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25337239)

  • 1. A four actin-binding protein signature model for poor prognosis of patients with esophageal squamous cell carcinoma.
    Peng ZM; Yu W; Xie Y; Peng WH; Cao HH; Shen JH; Wu ZY; Li EM; Xu LY
    Int J Clin Exp Pathol; 2014; 7(9):5950-9. PubMed ID: 25337239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.
    Zhang Y; Zhang YL; Chen HM; Pu HW; Ma WJ; Li XM; Ma H; Chen X
    World J Gastroenterol; 2014 May; 20(18):5533-9. PubMed ID: 24833884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma.
    Cao HH; Zhang SY; Shen JH; Wu ZY; Wu JY; Wang SH; Li EM; Xu LY
    Oncotarget; 2015 Mar; 6(7):5435-48. PubMed ID: 25605255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Fu XY; Ma QL; Wang XY; Lin P
    Oncotarget; 2016 Dec; 7(49):80493-80507. PubMed ID: 27563815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
    Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
    Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
    Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
    Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
    Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhu YH; Yang F; Zhang SS; Zeng TT; Xie X; Guan XY
    Int J Clin Exp Pathol; 2013; 6(11):2497-505. PubMed ID: 24228112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTA1: a prognosis indicator of postoperative patients with esophageal carcinoma.
    Song L; Wang Z; Liu X
    Thorac Cardiovasc Surg; 2013 Sep; 61(6):479-85. PubMed ID: 22547301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma.
    Kitaichi T; Yasui K; Gen Y; Dohi O; Iwai N; Tomie A; Yamada N; Terasaki K; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Naito Y; Zen Y; Itoh Y
    Hum Pathol; 2017 Apr; 62():134-140. PubMed ID: 28188749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of periostin is significantly correlated to the tumor angiogenesis and poor prognosis in patients with esophageal squamous cell carcinoma.
    Wang W; Sun QK; He YF; Ma DC; Xie MR; Ji CS; Hu B
    Int J Clin Exp Pathol; 2014; 7(2):593-601. PubMed ID: 24551279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.
    Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM
    Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus.
    Tzao C; Tung HJ; Jin JS; Sun GH; Hsu HS; Chen BH; Yu CP; Lee SC
    Mod Pathol; 2009 Feb; 22(2):252-60. PubMed ID: 18953329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma.
    Li M; Tang Y; Zang W; Xuan X; Wang N; Ma Y; Wang Y; Dong Z; Zhao G
    Diagn Pathol; 2013 Mar; 8():47. PubMed ID: 23531395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Wnt11 and Rock2 protein with clinical characteristics of esophageal squamous cell carcinoma in Kazakh and Han patients.
    Liu D; Zhou K; Li Q; Deng F; Ma Y
    Int J Clin Exp Pathol; 2015; 8(6):7122-30. PubMed ID: 26261605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
    Chen K; Cheng G; Zhang F; Zhang N; Li D; Jin J; Wu J; Ying L; Mao W; Su D
    Oncotarget; 2016 May; 7(21):30772-80. PubMed ID: 27120796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.